Business Description
Sihuan Pharmaceutical Holdings Group Ltd
NAICS : 325414
ISIN : BMG8162K1137
Compare
Compare
Traded in other countries / regions
00460.Hong KongTEL1.GermanySHPHF.USA IPO Date
2010-10-28Description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.57 | |||||
Equity-to-Asset | 0.38 | |||||
Debt-to-Equity | 0.28 | |||||
Debt-to-EBITDA | 3.76 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.95 | |||||
Beneish M-Score | -2.63 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -10.8 | |||||
3-Year EBITDA Growth Rate | -33.4 | |||||
3-Year FCF Growth Rate | 37 | |||||
3-Year Book Growth Rate | -23.3 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 45.69 | |||||
9-Day RSI | 47.91 | |||||
14-Day RSI | 48.13 | |||||
6-1 Month Momentum % | -10.34 | |||||
12-1 Month Momentum % | -21.21 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.51 | |||||
Quick Ratio | 1.37 | |||||
Cash Ratio | 1.09 | |||||
Days Inventory | 385.97 | |||||
Days Sales Outstanding | 79.83 | |||||
Days Payable | 130.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 32.2 | |||||
3-Year Average Share Buyback Ratio | 0.5 | |||||
Shareholder Yield % | 0.65 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 69.64 | |||||
Operating Margin % | -10.29 | |||||
Net Margin % | -2.9 | |||||
FCF Margin % | -5.16 | |||||
ROE % | -1.19 | |||||
ROA % | -0.45 | |||||
ROIC % | -4.37 | |||||
ROC (Joel Greenblatt) % | 3.68 | |||||
ROCE % | 1.21 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 7.57 | |||||
PS Ratio | 2.42 | |||||
PB Ratio | 1.02 | |||||
Price-to-Tangible-Book | 1.23 | |||||
Price-to-Operating-Cash-Flow | 23.04 | |||||
EV-to-EBIT | 11.94 | |||||
EV-to-EBITDA | 3.86 | |||||
EV-to-Revenue | 0.69 | |||||
EV-to-FCF | -13.51 | |||||
Price-to-Projected-FCF | 0.63 | |||||
Price-to-Median-PS-Value | 0.48 | |||||
Earnings Yield (Greenblatt) % | 8.38 | |||||
FCF Yield % | -2.12 | |||||
Forward Rate of Return (Yacktman) % | 27.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sihuan Pharmaceutical Holdings Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 2,035.02 | ||
EPS (TTM) (HK$) | -0.007 | ||
Beta | 1.05 | ||
Volatility % | 29.15 | ||
14-Day RSI | 48.13 | ||
14-Day ATR (HK$) | 0.017098 | ||
20-Day SMA (HK$) | 0.5295 | ||
12-1 Month Momentum % | -21.21 | ||
52-Week Range (HK$) | 0.49 - 0.71 | ||
Shares Outstanding (Mil) | 9,320 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Sihuan Pharmaceutical Holdings Group Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Sihuan Pharmaceutical Holdings Group Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Sihuan Pharmaceutical Holdings Group Ltd Frequently Asked Questions
What is Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460)'s stock price today?
The current price of HKSE:00460 is HK$0.53. The 52 week high of HKSE:00460 is HK$0.71 and 52 week low is HK$0.49.
When is next earnings date of Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460)?
The next earnings date of Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) is 2024-08-29 Est..
Does Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) pay dividends? If so, how much?
Sihuan Pharmaceutical Holdings Group Ltd(HKSE:00460) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |